Why the study?
Does plasma fructosamine measurement accurately substitute for HbA1c in assessing diabetic control?
Does plasma fructosamine measurement accurately substitute for HbA1c in assessing diabetic control?
Plasma fructosamine has low sensitivity compared to HbA1c and cannot be used as a substitute for assessing diabetic control.
Fructosamine's low sensitivity precludes routine HbA1c substitution; leaves open targeted evaluation in hemoglobinopathy or anemia.
The 'gold standard' marker of overall glycaemic control in diabetes mellitus is the level of glycated haemoglobin (HbA1c). It is, however, an expensive and technically difficult assay and is rarely appropriate to tropical laboratories. Plasma fructosamine measurement is cheaper and easier, though it reflects shorter-term glycaemia. We have measured both indices of control in a group of 154 diabetic patients. There was close correlation between the two measurements (r = 0.6506, P < 0.001), but many patients with abnormal HbA1c levels had normal fructosamine levels. This resulted in an assay sensitivity (compared with HbA1c as gold standard) of only 30%, though specificity was 98%. We conclude that fructosamine measurement cannot be regarded as a substitute for HbA1c determination.
No takes yet. Share an insight, caveat, or question.
Malik et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: